A randomized trial comparing induction gemcitabine and cisplatin plus intensity-modulated radiotherapy with concurrent cisplatin plus intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to verify that induction gemcitabine and cisplatin plus intensity-modulated radiotherapy (IMRT) is non-inferior to concurrent weekly cisplatin plus IMRT for patients with locoregionally advanced nasopharyngeal carcinoma (NPC).
Epistemonikos ID: 9fafc464538bb8beba7129eab65e0718fb0dc02e
First added on: May 12, 2024